Table 3.
Primary and Secondary Outcomes
| Odds ratio (95%CI) how vs usual care | Odds ratio (95%CI) why vs usual care | Odds ratio (95%CI) why vs how | |
|---|---|---|---|
| Vaccination from intervention delivery through scheduled visit (primary outcome) | |||
| Intention-to-treat analysis | |||
| Unadjusted | 0.87 (0.67 to 1.14) | 1.01 (0.81 to 1.28) | 1.20 (0.96 to 1.51) |
| Adjusted | 0.88 (0.68 to 1.15) | 1.04 (0.82 to 1.32) | 1.22 (0.97 to 1.54) |
| Sensitivity analysis | |||
| Unadjusted | 0.91 (0.70 to 1.18) | 0.90 (0.69 to 1.18) | 1.01 (0.78 to 1.32) |
| Adjusted | 0.91 (0.70 to 1.19) | 0.91 (0.69 to 1.20) | 1.02 (0.79 to 1.33) |
| Vaccination through 6 weeks after intervention delivery (secondary outcome) | |||
| Intention-to-treat analysis | |||
| Unadjusted | 0.83 (0.67 to 1.01) | 1.03 (0.87 to 1.23) | 1.26 (1.06 to 1.49) |
| Adjusted | 0.83 (0.68 to 1.01) | 1.05 (0.88 to 1.25) | 1.26 (1.07 to 1.50) |
| Sensitivity analysis | |||
| Unadjusted | 0.82 (0.65 to 1.04) | 0.96 (0.78 to 1.18) | 1.20 (0.95 to 1.53) |
| Adjusted | 0.82 (0.65 to 1.05) | 0.97 (0.78 to 1.20) | 1.21 (0.94 to 1.54) |
All analyses are adjusted for clustering of patients within clinic day and clinic. The adjusted analyses also adjust for race, sex, and ethnicity. Sensitivity analyses include only patients who were retrospectively eligible for booster at the time of randomization (N = 2045)
Abbreviation: CI confidence interval